Investors.com http://ift.tt/XfIefc Zeltiq (ZLTQ) shares soared a day after the maker of fat-freezing technology easily topped second-quarter estimates and lifted full-year guidance. Shares gapped up 32% on the stock market today, hitting a six-month high. Analysts at Maxim also raised their price target to 30 from 25 on Wednesday, citing the quarterly results. Zeltiq is a medical technology company whose primary commercial product, the FDA-approved, non-invasive CoolSculpting
No comments:
Post a Comment